The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Abstract
CONTEXT: Hepatitis C virus (HCV) infection may resolve (viral clearance), persist without complications, or cause end-stage liver disease (ESLD). The frequency and determinants of these outcomes are poorly understood. OBJECTIVE: To assess the incidence and determinants of viral clearance and ESLD among persons who acquired HCV infection from injection drug use. DESIGN AND SETTING: Community-based prospective cohort study with enrollment in 1988-1989 and a median follow-up of 8.8 years. SUBJECTS: A total of 1667 persons aged 17 years or older with a history of injection drug use and an HCV antibody-positive test result during follow-up. MAIN OUTCOME MEASURES: Viral clearance was assessed in a subset of 919 patients and defined as failure to detect HCV RNA in at least 2 consecutive samples collected 5 or more months apart. End-stage liver disease was assessed at semiannual visits and by review of medical records and death certificates and defined by the presence of ascites, esophageal varices, or hepatic encephalopathy, or when ESLD was stated as a cause of death. RESULTS: Viral clearance was observed in 90 persons who were compared with 722 with persistent viremia, while the viremia of 107 was not resolved. Viral clearance occurred more often in nonblacks (adjusted odds ratio [OR], 5.15; 95% confidence interval [CI], 2.60-10.17) and those not infected with human immunodeficiency virus (HIV) (adjusted OR, 2.19; 95% CI, 1.26-3.47). Forty cases of ESLD were observed throughout follow-up (incidence, 3.1 per 1000 person-years). In a multivariate model, risk of ESLD was higher for persons aged 38 years or older at enrollment (adjusted relative incidence, 3.67; 95% CI, 1.96-6.88) and who reported ingestion of more than 260 g of alcohol per week (adjusted relative incidence, 3.60; 95% CI, 1.73-7.52). Of 210 patients without ESLD randomly selected for biopsy, only 2 had cirrhosis. CONCLUSIONS: Our results indicate that although HCV infection can be self-limited or associated with ESLD, the majority of adults have persistent viremia without clinically demonstrable liver disease. Further research is needed to explain the less frequent clearance of HCV infection among black persons and to improve utilization of treatment for those infected in the context of injection drug use. JAMA. 2000;284:450-456
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,660
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Nishiguchi, S., Kuroki, T., Nakatani, S., Morimoto, H., Takeda, T., Nakajima, S., Shiomi, S., Seki, S., Kobayashi, K., & Otani, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91739-x · Cited by 857
Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
Lau, J. Y. N., Davis, G. L., Kniffen, J., Qian, K.-P., Urdea, M. S., Chan, C. S., Neuwald, P. D., Wilber, J. C., & Mizokami, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)90635-t · Cited by 795
Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., & Nelson, K. E. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.5.655 · Cited by 690
Self-citationLong-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.
Farci, P., Alter, H. J., Wong, D., Miller, R. H., Shih, J. W., Jett, B., & Purcell, R. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107113250205 · Cited by 571
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
McOmish, F., Yap, P. L., Dow, B. C., Follett, E. A., Seed, C., Keller, A. J., Cobain, T. J., Krusius, T., Kolho, E., & Naukkarinen, R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.884-892.1994 · Cited by 509
Vogt, M. O., Lang, T., Frösner, G., Klingler, C., Sendl, A., Zeller, A., Wiebecke, B., Langer, B., Meisner, H., & Hess, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411202 · Cited by 502
Darby, S. C., Ewart, D. W., Giangrande, P. L., Spooner, R. J., Rizza, C. R., Dusheiko, G. M., Lee, C. A., Ludlam, C. A., & Preston, F. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05413-5 · Cited by 497
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
Villano, S. A., Vlahov, D., Nelson, K. E., Cohn, S., & Thomas, D. L. (1999) · Hepatology · doi:10.1002/hep.510290311 · Cited by 475
Self-citationKasahara, A., Hayashi, N., Mochizuki, K., Takayanagi, M., Yoshioka, K., Kakumu, S., Iijima, A., Urushihara, A., Kiyosawa, K., Okuda, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270529 · Cited by 467
Eyster, M. E., Diamondstone, L. S., Lien, J., Ehmann, W. C., Quan, S., & Goedert, J. J. (1993) · PubMed · Cited by 421
Correlates of Hepatitis C Virus Infections among Injection Drug Users
Thomas, D. L., Vlahov, D., Solomon, L., Cohn, S., Taylor, E., Garfein, R., & Nelson, K. E. (1995) · Medicine · doi:10.1097/00005792-199507000-00005 · Cited by 362
Self-citation45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults
Seeff, L. B., Miller, R. N., Rabkin, C. S., Buskell-Bales, Z., Straley-Eason, K. D., Smoak, B. L., Johnson, L. D., Lee, S. R., & Kaplan, E. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00003 · Cited by 347
Self-citationPessione, F., Degos, F., Marcellin, P., Duchatelle, V., Njapoum, C., Martinot-Peignoux, M., Degott, C., Valla, D., Erlinger, S., & Rueff, B. (1998) · Hepatology · doi:10.1002/hep.510270635 · Cited by 340
Corrao, G., & Aricò, S. (1998) · Hepatology · doi:10.1002/hep.510270404 · Cited by 324
Role of alcohol in the progression of liver disease caused by hepatitis C virus infection
Ostapowicz, G., Watson, K. J., Locarnini, S. A., & Desmond, P. V. (1998) · Hepatology · doi:10.1002/hep.510270637 · Cited by 286
Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis
Tremolada, F., Casarin, C., Alberti, A., Drago, C., Tagger, A., Ribero, M. L., & Realdi, G. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80657-9 · Cited by 263
Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade
Koretz, R. L., Abbey, H., Coleman, E., & Gitnick, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00003 · Cited by 233
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland
Villano, S. A., Vlahov, D., Nelson, K. E., Lyles, C. M., Cohn, S., & Thomas, D. L. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3274-3277.1997 · Cited by 227
Self-citationHopf, U., Möller, B., Küther, D., Stemerowicz, R., Lobeck, H., Lüdtke-Handjery, A., Walter, E., Blum, H. E., Roggendorf, M., & Deinhardt, F. W. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90075-3 · Cited by 225
Vlahov, D., Graham, N., Hoover, D., Flynn, C., Bartlett, J. G., Margolick, J. B., Lyles, C. M., Nelson, K. E., Smith, D., Holmberg, S., et al. (1998) · JAMA · doi:10.1001/jama.279.1.35 · Cited by 215
Self-citationGretch, D., Corey, L., Wilson, J., dela Rosa, C., Willson, R., Carithers, R., Busch, M., Hart, J., Sayers, M., & Han, J. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.6.1219 · Cited by 210
Vlahov, D., Anthony, J. C., Muñoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., Solomon, L., & Polk, B. F. (1991) · Journal of Drug Issues · doi:10.1177/002204269102100406 · Cited by 194
Self-citationPersistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C
Barrera, J. M., Bruguera, M., Ercilla, G. M., Gil, C., Celis, R., Gil, P. M., Del Onorato, V. M., Rodés, J., & Ordinas, A. (1995) · Hepatology · doi:10.1002/hep.1840210306 · Cited by 185
Determinants of the Quantity of Hepatitis C Virus RNA
Thomas, D. L., Astemborski, J. A., Vlahov, D., Strathdee, S. A., Ray, S. C., Nelson, K. E., Galai, N., Nolt, K. R., Laeyendecker, O. B., & Todd, J. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315314 · Cited by 111
Self-citationMattsson, L., Sönnerborg, A. B., & Weiland, O. (1993) · Liver International · doi:10.1111/j.1600-0676.1993.tb00644.x · Cited by 108
Moliner, L. D., Pontisso, P., Salvo, G. L. D., et al. (1998) · Gut · doi:10.1136/gut.42.6.856 · Cited by 108
Haydon, G. H., Jarvis, L. M., Blair, C. S., et al. (1998) · Gut · doi:10.1136/gut.42.4.570 · Cited by 90
Inglesby, T. V., Rai, R., Astemborski, J. A., Gruskin, L., Nelson, K. E., Vlahov, D., & Thomas, D. L. (1999) · Hepatology · doi:10.1002/hep.510290219 · Cited by 88
Self-citation
Cited by
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
Self-citationNatural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
Panel, A. H. G. (2015) · Hepatology · doi:10.1002/hep.27950 · Cited by 1,382
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179
Self-citationRauch, A., Kutalik, Z., Descombes, P., Cai, T., Di Iulio, J., Mueller, T., Bochud, M., Battegay, M., Bernasconi, E., Borovicka, J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.056 · Cited by 1,137
Metadata
- Authors
- Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., Laeyendecker, O., Boitnott, J., Wilson, L. E., & Vlahov, D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2000-07-26
- Volume
- 284
- Issue
- 4
- Pages
- 450-6
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2119168386
- Cited by
- 1,073
- References
- 38
- FWCI
- 28.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.